Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Formulation Development Outsourcing Market Size And Revenue Outlook Through 2030
The formulation development outsourcing market size has experienced significant expansion in recent years. It will grow from $32.32 billion in 2025 to $35.45 billion in 2026 at a compound annual growth rate (CAGR) of 9.7%. The historical increase can be attributed to several factors, including the increasing complexity of pharmaceutical research and development, a rising number of drug candidates in pipelines, the growing demand for specialized formulation expertise, the expansion of contract research partnerships, and increasing regulatory scrutiny in drug development.
The formulation development outsourcing market is projected to experience swift expansion in the coming years. This market is set to reach a size of $53.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.7%. This projected growth can be attributed to several factors, including a heightened demand for biologics and intricate formulations, an increase in outsourcing by nascent pharmaceutical firms, the expansion of personalized medicine initiatives, wider adoption of sophisticated formulation techniques, and a stronger emphasis on speeding up market entry. Key trends anticipated during this period encompass a greater reliance on outsourcing for complex drug formulations, a growing embrace of quality by design methodologies, an escalating need for injectable and specialized dosage forms, the expansion of services related to scale-up and technology transfer, and a reinforced commitment to developing formulations that adhere to regulatory standards.
Get A Free Sample Report With In-Depth Market Insights:
Formulation Development Outsourcing Market Opportunity Drivers: What’s Unlocking New Revenue Potential?
The increasing demand for drugs is anticipated to drive the expansion of the formulation development outsourcing market. Drugs refer to substances that serve various purposes, such as medical treatment, disease prevention, symptom relief, or recreational use. Formulation development outsourcing plays a vital role in drug development by aiding in the creation of biopharmaceuticals and novel drug delivery systems, speeding up the drug development process, and providing an economical solution for pharmaceutical companies, among other benefits. For instance, according to Eurostat, a government agency based in Luxembourg, in April 2025, it was reported that EU exports of medicinal and pharmaceutical products grew by 13.5% in 2024 compared to 2023, reaching $316.38 billion (€313.4 billion). During the same period, imports recorded a minimal increase of 0.5%, totaling $112.7 billion (€119.7 billion). Consequently, the rising demand for drugs is fueling the growth of the formulation development outsourcing market.
Formulation Development Outsourcing Market Segment Breakdown: Which Categories Lead On Revenue?
The formulation development outsourcing market covered in this report is segmented –
1) By Service: Preformulation, Formulation Development
2) By Therapeutic Area: Oncology, Infectious Disease, Neurology, Hematology, Respiratory, Cardiovascular, Dermatology, Other Therapeutics
3) By Formulation: Oral, Injectable, Topical, Other Formulations
4) By End-User: Pharmaceutical Industries, Research And Academic Development
Subsegments:
1) By Preformulation: Physicochemical Characterization, Stability Testing, Formulation Feasibility Studies, Analytical Method Development
2) By Formulation Development: Drug Formulation Development, Process Development, Scale-Up And Technology Transfer, Quality By Design (QbD) Development
Formulation Development Outsourcing Market Innovation Trends Shaping Future Development
Leading companies in the formulation development outsourcing market are focusing on creating innovative solutions, such as AI powered generative cloud platforms, to address the increasing demand for accelerated drug discovery, optimized molecular design, and more efficient R&D workflows. These Generative AI cloud platforms utilize pre trained machine learning models and high performance computing to automate and enhance complex tasks in drug formulation and discovery. They provide significant improvements over traditional computational chemistry and manual screening methods by enabling rapid protein structure prediction, molecule generation, and data driven optimization at scale. For instance, in March 2023, NVIDIA, a US based software technology company, introduced BioNeMo Cloud, a generative AI service within its AI Foundations suite. This service aims to accelerate life sciences research, drug discovery, and protein engineering by giving researchers access to customizable, pre trained AI models that can be fine tuned with proprietary data to support tasks such as target identification and molecular design, directly through cloud APIs or a web browser interface. This cloud based platform features optimized generative AI workflows for protein structure prediction, docking, and molecule generation, which helps shorten the most time consuming stages of drug development compared with conventional in house computational efforts and manual experimentation. It has been adopted by companies like Amgen and several biotech startups to drive faster, data driven innovation.
Formulation Development Outsourcing Market Company Landscape And Competitive Strategy
Major companies operating in the formulation development outsourcing market include Syngene International Ltd., Aizant Drug Research Solutions Private Limited., Catalent Inc., Intertek Group plc, Recipharm AB, SGS S.A., Lonza Group AG, Eurofins Scientific SE, Laboratory Corporation of America Holdings, Charles River Laboratories International Inc., Emergent Biosolutions Inc., IRISYS LLC, Piramal Pharma Limited., Biocon Limited., Dr Reddy’s Laboratories Ltd., Quotient Sciences Ltd., Almac Group, Patheon, Evonik Industries AG, Metrics Contract Services, Aenova Group, Fareva Group, Vetter Pharma International GmbH, Aesica Pharmaceuticals, WuXi AppTec, Formosa Laboratories Inc., Aptuit LLC, ProPharma Group, Laurus Labs Limited
View The Full Formulation Development Outsourcing Market Report:
Formulation Development Outsourcing Market Largest Region: Which Geography Holds The Biggest Share?
North America was the largest region in the global formulation development outsourcing market in 2025. The regions covered in the formulation development outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.